{"schema":"hottub-news/story/v1","story":"st_lttu7lgs56pzz7vhtuya","title":"Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology","title_en":null,"outlets":2,"brief":null,"page":"https://hottub.news/stories/zealand-pharma-to-present-additional-data-from-phase-2-zupreme-1-trial-lttu7lgs56","count":2,"items":[{"id":"n_kuzdc5yvijted4a6ykyq","seq":780782,"kind":"article","title":"Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology","url":"https://www.manilatimes.net/2026/09/30/tmt-newswire/globenewswire/zealand-pharma-to-present-additional-data-from-phase-2-zupreme-1-trial-for-petrelintide-at-easd-2026-and-announces-publication-of-trial-results-in-the-lancet-diabetes-endocrinology/2435635","published":"2026-09-29T22:10:00Z","seen":"2026-09-29T22:40:41Z","lang":"en","source":{"id":"manilatimes.net","name":"manilatimes.net","domain":"manilatimes.net","outlet":{"wikidata":"Q1573100","name":"The Manila Times","type":"magazine","country":"PH","designations":["organization","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","health","business"],"entities":[{"id":"Q18552286","name":"Zealand Pharma","type":"org"}],"story":"st_lttu7lgs56pzz7vhtuya","category":"health","category_p":0.6299999952316284,"sentiment":"neutral","tone":-0.10000000149011612,"political":0.05000000074505806},{"id":"n_lttu7lgs56pzz7vhtuya","seq":775222,"kind":"press_release","title":"Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology","url":"https://www.globenewswire.com/news-release/2026/09/29/3371443/0/en/zealand-pharma-to-present-additional-data-from-phase-2-zupreme-1-trial-for-petrelintide-at-easd-2026-and-announces-publication-of-trial-results-in-the-lancet-diabetes-endocrinology.html","summary":"Press release – No. 18 / 2026","published":"2026-09-29T22:03:00Z","seen":"2026-09-29T22:08:15Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business","copenhagen:zeal","dk0060257814","7714"],"entities":[{"id":"Q18552286","name":"Zealand Pharma","type":"org"}],"mentions":2,"story":"st_lttu7lgs56pzz7vhtuya","category":"health","category_p":0.6299999952316284,"sentiment":"neutral","tone":0.30000001192092896,"political":0.05000000074505806}]}